EYETECH PHARMACEUTICALS INC 4
4 · EYETECH PHARMACEUTICALS INC · Filed Aug 1, 2005
Insider Transaction Report
Form 4
GUYER DAVID R
DirectorChief Executive Officer
Transactions
- Sale
Common Stock
2005-08-01$11.33/sh−15,600$176,748→ 1,178,239 total
Holdings
- 30,000(indirect: By Trust)
Common Stock
Footnotes (2)
- [F1]Transaction made pursuant to a 10b5-1 Plan dated April 25, 2005.
- [F2]These shares are held in a trust for the benefit of the reporting person's children. The reporting person's mother is trustee of the Trust. The reporting person disclaims beneficial ownership of these securites and the filing of this report is not an admission that the reporting person is a beneficial owner of these securities for Section 16 or any other purpose.